<code id='32E73F79AA'></code><style id='32E73F79AA'></style>
    • <acronym id='32E73F79AA'></acronym>
      <center id='32E73F79AA'><center id='32E73F79AA'><tfoot id='32E73F79AA'></tfoot></center><abbr id='32E73F79AA'><dir id='32E73F79AA'><tfoot id='32E73F79AA'></tfoot><noframes id='32E73F79AA'>

    • <optgroup id='32E73F79AA'><strike id='32E73F79AA'><sup id='32E73F79AA'></sup></strike><code id='32E73F79AA'></code></optgroup>
        1. <b id='32E73F79AA'><label id='32E73F79AA'><select id='32E73F79AA'><dt id='32E73F79AA'><span id='32E73F79AA'></span></dt></select></label></b><u id='32E73F79AA'></u>
          <i id='32E73F79AA'><strike id='32E73F79AA'><tt id='32E73F79AA'><pre id='32E73F79AA'></pre></tt></strike></i>

          hotspot

          hotspot

          author:comprehensive    Page View:3
          Cambridge: AbbVie
          The pharma giant AbbVie spent nearly $4 million on lobbying in the first three months of 2022 — nearly a million dollars more than the company has ever spent in a single quarter. Ruby Wallau for STAT

          WASHINGTON — The pharma giant AbbVie spent nearly $4 million on lobbying in the first three months of 2022 alone — more than any other drugmaker spent in the same period, and nearly a million dollars more than the company spent in the same period last year.

          AbbVie was the seventh-highest corporate lobbying spender last quarter, ahead of giants like Lockheed Martin, CVS Health, and, AT&T, federal records show.

          advertisement

          The number is eye-popping even for the pharmaceutical industry, which is known for its omnipresence on Capitol Hill, and its nearly unlimited lobbying budgets.

          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

          GET STARTED Log In

          explore

          BioMarin wins approval for gene therapy to treat hemophilia A
          BioMarin wins approval for gene therapy to treat hemophilia A

          AdobeTheFoodandDrugAdministrationonThursdayapprovedagenetherapytotreatpeoplewithhemophiliaA,aninheri

          read more
          CommonSpirit Health keeps growing, even as it loses money
          CommonSpirit Health keeps growing, even as it loses money

          CommonSpirit,oneofthecountry’sbiggesthealthsystems,keepsgrowingitshospitalcountanddebt,evenasitloses

          read more
          As demand for Covid shots wanes, Moderna seeks its next success
          As demand for Covid shots wanes, Moderna seeks its next success

          RubyWallauforSTATModernachairmanNoubarAfeyanexudedstarpowerearlierthismonthashecommandedthespotlight

          read more

          STAT Virtual Event: Putting AI to the Test

          Editor’snote:Alivestreamoftheeventisembeddedbelow.Enoughtalkaboutfairness,safety,andeffective